HEALTH● LOWJun 26 · Jun 26, 2026, 12:22 PM
Replimune to face AdCom panel as lead drug accepted for FDA review
Seeking Alpha Tech
Replimune's lead drug has been accepted for FDA review and is slated to face an AdCom panel.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH44m agoEbola: Africa CDC mourns as DRC doctor dies from virusPremium TimesHEALTH1h agoWhich vaccinations should you have this autumn and which are recommended in GermanyEuroNews [en]HEALTH1h agoScientists confirm fruit and vegetable skin really is good for youNew ScientistHEALTH1h agoNipah medicine row: Action after receiving expert panel report, says Keralam Health MinisterThe Hindu